DMCC Speciality Chemicals Ltd has disclosed the identity of its promoters and Persons Acting in Concert (PAC) to the National Stock Exchange of India Ltd and BSE Limited. The filing confirms that the promoter and promoter group did not create any encumbrance, directly or indirectly, on the shares held by them in the company during the financial year ended March 31, 2026. This disclosure was made in compliance with Regulation 31(4) of the Securities & Exchange Board of India (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

The submission was made by Bimal Lalitsingh Goculdas, a member of the Promoter Group and the Managing Director & CEO of the company. The letter addressed the Listing Department of the NSE and the Department of Corporate Services at the BSE, formally recording the status of shareholding for the specified period.

Promoter and PAC Details

The document lists the entities classified as promoters and members of the promoter group. The table below provides the names and entity types as disclosed in the regulatory filing.

The company was formerly known as The Dharamsi Morarji Chemical Company Limited. The disclosure was copied to the Company Secretary and the Audit Committee of DMCC Speciality Chemicals Ltd for their records.

DMCC Speciality Chemicals Limited has filed the transcript of its earnings conference call held on Tuesday, May 19, 2026, regarding the financial performance of Q4 FY26. The filing was made in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The transcript is accessible via the company's official website.

Earlier, the company announced its audited financial results for the quarter and full year ended March 31, 2026. For Q4, the company reported a Profit After Tax (PAT) of ₹7.65 Cr, rising 18.27% year-on-year from ₹6.47 Cr. Revenue from operations stood at ₹177.64 Cr, surging 41.87% YoY from ₹125.22 Cr. The Board of Directors recommended a final dividend of 25% (₹2.50 per equity share of ₹10 each) for FY26, subject to shareholder approval.

Q4 Financial Highlights

The company delivered broad-based growth across key metrics in Q4. EBITDA rose 14.73% YoY to ₹17.86 Cr, while EBITDA margins stood at 10.05%. Profit Before Tax grew 15.79% YoY to ₹10.81 Cr. Basic and Diluted EPS for Q4 stood at ₹3.07.

Full Year FY26 Performance

For the full year FY26, PAT grew 26.95% to ₹27.33 Cr from ₹21.53 Cr in FY25. Annual revenue from operations rose 34.84% to ₹581.58 Cr. Annual EBITDA rose 10.23% to ₹64.33 Cr, while EBITDA margins contracted 245 basis points to 11.04%.

Management Commentary

During the earnings call, Managing Director and CEO Mr. Bimal Goculdas highlighted that the Middle East crisis significantly impacted sulfur availability and pricing, with about 50% of global sulfur trade flowing through the Strait of Hormuz. Consequently, the Roha plant operated at reduced capacity (approximately 60%) for around 15 days in March to manage raw material shortages, while the Dahej plant operated normally using domestic sourcing.

Regarding the boron chemicals business, the first half of the year saw production losses due to supply disruption from Turkey, but operations resumed at full capacity in the second half. The company has also replaced most of its reduced European business with orders from Latin America and is developing markets in Japan, Korea, and China.

Corporate Developments

The board recommended a final dividend of ₹2.50 per share for FY26. The company's 105th Annual General Meeting is scheduled for Friday, September 11, 2026, via Video Conferencing. Additionally, the board appointed Shri S. S. Dongare as Cost Auditor for FY27.